GHO Capital announces two acquisitions to create pan-European ophthalmic specialty pharmaceutical company
Target: Visufarma Spa / Nicox S.A.
Country: italy / france
Buyer: GHO Capital
Transaction: GHO Capital, the European specialist investor in healthcare, has entered into an agreement to acquire the European commercial operations of Nicox S.A., the international ophthalmic company, and to acquire the entire issued share capital of Visufarma Spa, a private Italian ophthalmic company. The combined platform will create a new pan-European ophthalmic specialty pharmaceutical company with sales and marketing infrastructure to commercialise a broad portfolio of products across international markets. Further details will be disclosed upon completion. …